Premium High-purity Peptides Retatrutide 5mg + Cagrilintide 5mg

Retatrutide 5mg + Cagrilintide 5mg are not single peptides, but a powerful combination of two of the most advanced peptide drugs currently being researched in the field of metabolism. If weight loss is likened to a war, Retatrutide is like a heavy missile simultaneously striking three targets, while Cagrilintide is like a special forces unit responsible for cutting off the enemy's supply lines. Their combination aims to break through the limitations of monotherapy and achieve ultimate weight control.

Core Ingredients: Retatrutide (GLP-1/GIP/glucagon triple receptor agonist) + Cagrilintide (long-acting amylin analogue)

Common Form: Research-grade lyophilized powder (usually a 5mg + 5mg mixture)

Administration: Subcutaneous injection (once a week)

Mechanism of Action: Synergistic effect of four pathways (GLP-1R + GIPR + GCGR + AMYR)

Breaking Through the Weight Loss Ceiling: This is the biggest highlight of this combination. Retatrutide itself increases the body's energy expenditure by activating glucagon receptors (essentially burning fat even while lying down). Clinical data shows that its monotherapy can achieve a weight loss of over 24% in 48 weeks; while Cagrilintide strongly suppresses appetite and delays gastric emptying. The combination of the two not only significantly reduces calorie intake but also dramatically increases calorie expenditure, resulting in a weight loss effect far exceeding that of current semaglutide or telpolide.

Comprehensive Metabolic Remodeling: It's more than just losing weight. Retatrutide significantly reduces liver fat (extremely beneficial for fatty liver disease) and improves insulin sensitivity; Cagrilintide further optimizes blood sugar homeostasis. For individuals with metabolic syndrome, it delivers transformative improvements in physical indicators.

Preserving muscle mass, precise fat loss: Many potent weight-loss drugs lead to significant muscle loss, but research shows that this combination, while reducing substantial fat, better protects lean body mass (muscle). This means that after weight loss, your physique will be more toned, and your basal metabolic rate is less likely to plummet.

Deep satiety: Cagrilintide acts on the satiety center in the hypothalamus of the brain, fundamentally eliminating the compulsive hunger pangs of constantly thinking about food, making diet control less painful.

Strong gastrointestinal reactions: Due to its potent effects, the incidence of nausea, vomiting, diarrhea, and constipation is very high, especially when starting medication or increasing the dosage. The body may experience a challenging adaptation period.

Risk of Increased Heart Rate: The glucagon component in Retatrutide may increase resting heart rate by 5-10 beats per minute, which is a potential concern for individuals with pre-existing heart conditions.

Currently for Research Use Only: This combination is highly advanced and is currently mostly in clinical trials or research phases globally, not yet officially approved for regular prescription use. Commercially available products are mostly laboratory reagents, lacking the stringent purity and safety regulations typically associated with medical-grade drugs.

Severely obese individuals (BMI ≥ 30) or overweight individuals with severe complications who have not responded well to existing single- or dual-target drugs.

Specific research groups with non-alcoholic fatty liver disease (NAFLD/MASLD) who urgently need fat reduction and liver protection.

Experimental models with severe metabolic disorders requiring strong intervention for insulin resistance and dyslipidemia.

Strictly prohibited for unauthorized human use: Again, this is currently a research raw material, not a finished drug. Unauthorized preparation and injection without professional medical guidance and proper medical channels pose significant safety risks. Thyroid and Pancreatic Contraindications: Individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2) should absolutely avoid these medications. Those with a history of pancreatitis should also exercise extreme caution.

Pay Attention to Body Signals: If persistent, severe abdominal pain (which may be a sign of pancreatitis), a neck lump, or a severe allergic reaction occurs, discontinue use immediately and seek emergency medical help.

The Necessity of Gradual Increment: In standard clinical trials, these medications are typically started at very low doses and gradually increased to allow the body time to adapt. High doses should never be used immediately, as the side effects could be devastating.

Hot Tags: Premium High-purity Peptides Retatrutide 5mg + Cagrilintide 5mg, China Premium High-purity Peptides Retatrutide 5mg + Cagrilintide 5mg manufacturers, suppliers, factory